Mannheim: the bottleneck in pediatric pain relievers – Regional Economy

By Matthias Croese

Mannheim. In Germany, pharmacies are currently experiencing bottlenecks in the delivery of children’s medicines. The Federal Institute for Medicines and Medical Devices (BfArM) confirmed in a statement that there is a particular shortage of fever juices that contain active ingredients such as ibuprofen and paracetamol. So extensive research and testing has already been done. After that, the bottlenecks are mainly due to the withdrawal of the service provider. In addition, there is also a “distribution problem”. Finally, the demand for the drugs in question has risen disproportionately this year. The reasons for this have not been satisfactorily identified.

In addition to corona, other infectious diseases are currently on the rise in Germany. Fever is a common symptom in children. Since syrups and suppositories are not yet normally able to swallow tablets, they are considered a form of administering the active ingredients particularly suitable for children. However, juices do not have as long a shelf life as tablets, and therefore are not profitable for manufacturers. Therefore, many have shifted production to Asia, where a large proportion of medicines have been stuck in ports for months due to the Corona lockdown.

The wholesaler of medicines Phoenix in Mannheim is responsible for distributing medicines. The company describes itself as a “leading integrated healthcare provider” and supplies about 60,000 pharmacies in Europe with nearly 40,000 employees. When asked about RNZ, Phoenix herself did not want to comment on the problem of painkillers and instead referred to the Pharmaceutical Wholesalers Association (PHAGRO), to which Mannheimer themselves belong. “Currently, wholesale drug companies cannot fully process orders for juices containing paracetamol or ibuprofen,” an association spokeswoman said. The causes of delivery bottlenecks are varied and range from

Leave a Comment